Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Fenghuang Zhan

Concepts (592)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Multiple Myeloma
139
2025
2999
10.220
Why?
Gene Expression Regulation, Neoplastic
53
2025
853
3.140
Why?
Drug Resistance, Neoplasm
25
2020
324
2.960
Why?
Plasma Cells
24
2025
234
2.870
Why?
Gene Expression Profiling
44
2025
1101
2.740
Why?
Monoclonal Gammopathy of Undetermined Significance
9
2025
120
2.630
Why?
Cell Proliferation
25
2022
1017
2.080
Why?
Antineoplastic Agents
29
2020
1214
1.990
Why?
Cell Line, Tumor
46
2025
1418
1.870
Why?
Neoplastic Stem Cells
7
2020
90
1.590
Why?
Pyrazines
19
2023
188
1.480
Why?
Disease Progression
19
2025
866
1.480
Why?
Mice
48
2025
5877
1.380
Why?
Humans
161
2025
52114
1.370
Why?
Paraproteinemias
9
2024
72
1.360
Why?
Lymphoma, B-Cell
5
2021
61
1.330
Why?
Apoptosis
18
2025
1117
1.330
Why?
Prognosis
39
2025
2093
1.300
Why?
Bone Resorption
6
2024
302
1.290
Why?
Boronic Acids
17
2014
181
1.290
Why?
Animals
59
2025
13332
1.200
Why?
Tumor Microenvironment
6
2024
246
1.170
Why?
Neoplasm Proteins
7
2021
328
1.120
Why?
Osteolysis
4
2022
74
1.050
Why?
B-Lymphocytes
8
2021
180
1.010
Why?
Cell Cycle Proteins
4
2023
167
0.970
Why?
T-Lymphocytes
8
2024
316
0.950
Why?
Hematopoietic Stem Cell Transplantation
6
2024
597
0.920
Why?
Ubiquitination
3
2021
57
0.880
Why?
Proteasome Inhibitors
7
2020
101
0.870
Why?
Signal Transduction
21
2023
1699
0.820
Why?
Proteasome Endopeptidase Complex
4
2018
138
0.770
Why?
MicroRNAs
7
2022
385
0.770
Why?
Antigens, CD
8
2024
215
0.720
Why?
Neoplasms
3
2024
1288
0.700
Why?
Iron
3
2017
130
0.670
Why?
Ascorbic Acid
2
2017
25
0.660
Why?
Carrier Proteins
3
2017
316
0.620
Why?
CDC2-CDC28 Kinases
3
2015
11
0.620
Why?
Cation Transport Proteins
2
2019
26
0.610
Why?
Chromosome Aberrations
7
2025
295
0.610
Why?
Ubiquitins
2
2016
18
0.590
Why?
Up-Regulation
6
2020
459
0.590
Why?
Cyclin-Dependent Kinases
2
2010
26
0.590
Why?
Mice, Inbred NOD
5
2020
90
0.580
Why?
Oligonucleotide Array Sequence Analysis
19
2014
411
0.580
Why?
Glycolysis
3
2022
72
0.580
Why?
Waldenstrom Macroglobulinemia
1
2018
38
0.580
Why?
Cell Survival
11
2020
596
0.560
Why?
Cell Differentiation
9
2023
670
0.550
Why?
Proto-Oncogene Proteins c-akt
5
2023
170
0.550
Why?
Pyrimidines
3
2015
198
0.540
Why?
STAT3 Transcription Factor
4
2016
86
0.540
Why?
Killer Cells, Natural
5
2024
112
0.530
Why?
Pyruvate Kinase
1
2017
7
0.530
Why?
Antineoplastic Combined Chemotherapy Protocols
10
2024
1020
0.520
Why?
RNA Splicing
1
2017
41
0.510
Why?
Female
46
2025
28055
0.490
Why?
Protein-Tyrosine Kinases
2
2015
87
0.480
Why?
Down-Regulation
9
2019
343
0.480
Why?
Male
36
2025
26652
0.480
Why?
Cyclopentanes
1
2015
12
0.470
Why?
Transplantation, Autologous
5
2024
480
0.470
Why?
Thalidomide
10
2023
377
0.470
Why?
Cyclin-Dependent Kinase Inhibitor p21
1
2015
68
0.460
Why?
Aldehyde Dehydrogenase
1
2014
24
0.450
Why?
Osteoclasts
7
2023
427
0.450
Why?
Dexamethasone
7
2024
435
0.440
Why?
Cyclin-Dependent Kinase Inhibitor p27
2
2020
17
0.430
Why?
Flow Cytometry
8
2018
397
0.420
Why?
Hematologic Neoplasms
1
2015
100
0.420
Why?
Models, Biological
5
2018
731
0.410
Why?
Receptors, Retinoic Acid
2
2013
22
0.410
Why?
Cystatin M
2
2024
17
0.410
Why?
RNA, Messenger
13
2021
1135
0.400
Why?
B-Cell Maturation Antigen
2
2024
92
0.390
Why?
Antigens, Neoplasm
6
2014
146
0.390
Why?
Aged
26
2025
10142
0.380
Why?
Mice, Transgenic
7
2021
560
0.380
Why?
Glucuronidase
4
2018
47
0.380
Why?
Predictive Value of Tests
5
2016
939
0.360
Why?
Antibodies, Bispecific
2
2023
88
0.350
Why?
Syndecan-1
6
2017
73
0.350
Why?
Receptors, TNF-Related Apoptosis-Inducing Ligand
1
2010
6
0.340
Why?
Arsenicals
1
2010
15
0.340
Why?
TNF-Related Apoptosis-Inducing Ligand
1
2010
20
0.340
Why?
Oxides
1
2010
21
0.340
Why?
Reverse Transcriptase Polymerase Chain Reaction
12
2015
580
0.330
Why?
Janus Kinase 1
1
2010
16
0.330
Why?
Proto-Oncogene Proteins c-jun
2
2009
76
0.330
Why?
Middle Aged
25
2025
13028
0.330
Why?
MAP Kinase Kinase 1
1
2010
23
0.330
Why?
Immunotherapy, Adoptive
2
2024
155
0.330
Why?
DNA-Binding Proteins
4
2021
424
0.320
Why?
Extracellular Signal-Regulated MAP Kinases
1
2010
83
0.320
Why?
Early Growth Response Protein 1
1
2009
34
0.310
Why?
Transcription Factors
6
2022
564
0.310
Why?
Lymphoma, Large B-Cell, Diffuse
2
2024
105
0.310
Why?
Oligopeptides
3
2015
92
0.300
Why?
Tretinoin
1
2009
53
0.300
Why?
Membrane Proteins
4
2018
328
0.300
Why?
Xenograft Model Antitumor Assays
7
2019
216
0.300
Why?
Osteogenesis
5
2023
365
0.290
Why?
NF-kappa B
3
2018
329
0.290
Why?
Tumor Cells, Cultured
6
2020
445
0.280
Why?
Genes, Neoplasm
1
2008
31
0.280
Why?
Antibodies
3
2024
148
0.280
Why?
Microarray Analysis
3
2018
69
0.280
Why?
Adult
22
2025
14095
0.270
Why?
Chromosomes, Human, Pair 1
4
2023
95
0.270
Why?
Oxidative Stress
5
2017
809
0.270
Why?
Immunologic Factors
5
2015
117
0.270
Why?
Interleukin-6
3
2019
274
0.270
Why?
S-Phase Kinase-Associated Proteins
1
2007
2
0.270
Why?
Retrospective Studies
8
2025
6610
0.260
Why?
Neoplasms, Plasma Cell
2
2023
35
0.260
Why?
Tumor Suppressor Protein p53
2
2008
224
0.260
Why?
Small Molecule Libraries
2
2019
66
0.260
Why?
Aged, 80 and over
8
2025
3382
0.260
Why?
Pyrazoles
2
2020
113
0.260
Why?
Mice, SCID
9
2018
178
0.240
Why?
CD8-Positive T-Lymphocytes
3
2024
128
0.240
Why?
Endopeptidase Clp
1
2025
2
0.240
Why?
Protein Kinase Inhibitors
3
2024
225
0.240
Why?
Risk Factors
11
2018
3922
0.230
Why?
Genomics
2
2023
265
0.230
Why?
Survival Rate
8
2020
945
0.230
Why?
Enzyme Inhibitors
4
2019
371
0.230
Why?
Bone Diseases
4
2016
92
0.230
Why?
Bone Marrow
7
2024
361
0.220
Why?
Polycomb Repressive Complex 2
2
2021
48
0.220
Why?
ROC Curve
1
2025
250
0.220
Why?
Diffusion Magnetic Resonance Imaging
1
2025
132
0.220
Why?
Single-Cell Analysis
1
2025
71
0.220
Why?
Transcriptome
2
2025
363
0.210
Why?
Propionates
1
2024
23
0.210
Why?
Receptors, LDL
1
2024
73
0.210
Why?
Hydroxybenzoates
1
2024
24
0.210
Why?
TNF Receptor-Associated Factor 3
2
2022
13
0.210
Why?
Ferritins
1
2024
36
0.210
Why?
Myeloid Progenitor Cells
1
2023
15
0.210
Why?
X-Ray Microtomography
1
2024
77
0.210
Why?
Melphalan
3
2023
178
0.210
Why?
Neoplasms, Second Primary
1
2024
75
0.210
Why?
Histocompatibility Antigens Class I
2
2015
47
0.210
Why?
Bone Marrow Cells
4
2015
189
0.210
Why?
Antigens, CD19
3
2018
28
0.210
Why?
Cholesterol
1
2024
160
0.210
Why?
Proteolysis
4
2018
102
0.210
Why?
Positron-Emission Tomography
1
2025
297
0.210
Why?
Membrane Glycoproteins
6
2009
238
0.200
Why?
Cell Transformation, Neoplastic
1
2024
184
0.200
Why?
Genes, myc
3
2019
39
0.200
Why?
Intercellular Signaling Peptides and Proteins
4
2007
106
0.200
Why?
Proto-Oncogene Proteins c-myc
3
2025
53
0.200
Why?
Lymphoma
1
2024
71
0.200
Why?
Bone Diseases, Metabolic
1
2024
78
0.200
Why?
Colonic Neoplasms
2
2022
162
0.200
Why?
Homeostasis
1
2024
205
0.200
Why?
Cluster Analysis
5
2009
236
0.200
Why?
Gene Knockdown Techniques
3
2018
108
0.200
Why?
Bone and Bones
2
2021
492
0.200
Why?
Phenols
1
2024
92
0.200
Why?
Neutropenia
1
2023
113
0.190
Why?
NM23 Nucleoside Diphosphate Kinases
1
2022
4
0.190
Why?
Protein Binding
2
2018
665
0.190
Why?
Recurrence
7
2018
680
0.190
Why?
Periodontitis
1
2022
11
0.190
Why?
Randomized Controlled Trials as Topic
6
2016
608
0.190
Why?
Antibodies, Monoclonal
3
2013
475
0.190
Why?
Case-Control Studies
8
2020
1193
0.190
Why?
In Situ Hybridization, Fluorescence
5
2023
262
0.190
Why?
Reactive Oxygen Species
4
2017
421
0.190
Why?
Carcinoma, Non-Small-Cell Lung
1
2024
166
0.180
Why?
Osteoporosis
1
2023
160
0.180
Why?
Protein Stability
2
2020
45
0.180
Why?
Kaplan-Meier Estimate
5
2016
482
0.180
Why?
Arthritis, Rheumatoid
1
2022
116
0.180
Why?
Mitochondria
1
2025
421
0.180
Why?
Heterogeneous-Nuclear Ribonucleoprotein Group A-B
1
2021
1
0.180
Why?
Nuclear Factor 90 Proteins
1
2021
1
0.180
Why?
RANK Ligand
1
2022
187
0.170
Why?
Venous Thromboembolism
3
2011
75
0.170
Why?
Gene Expression Regulation
3
2022
1000
0.170
Why?
Gene Expression
4
2017
618
0.170
Why?
Phenylpropionates
1
2021
13
0.170
Why?
Hippurates
1
2021
10
0.170
Why?
Cell Cycle
4
2010
237
0.170
Why?
Bone Neoplasms
2
2015
184
0.170
Why?
Adaptor Proteins, Signal Transducing
1
2021
198
0.170
Why?
Ubiquitin-Protein Ligases
2
2020
136
0.170
Why?
Treatment Outcome
12
2020
5456
0.170
Why?
Protease Inhibitors
3
2011
59
0.170
Why?
Receptors, G-Protein-Coupled
1
2021
54
0.170
Why?
Antigens, CD20
2
2014
6
0.170
Why?
Neoplasm Metastasis
4
2015
236
0.170
Why?
Cell Movement
2
2015
273
0.170
Why?
Time Factors
8
2021
2970
0.170
Why?
Evolution, Molecular
1
2021
95
0.160
Why?
Leukemia, Lymphocytic, Chronic, B-Cell
2
2015
59
0.160
Why?
Disease-Free Survival
7
2016
462
0.160
Why?
Colorectal Neoplasms
2
2022
292
0.160
Why?
Practice Guidelines as Topic
1
2023
494
0.160
Why?
Chromosomal Instability
3
2021
16
0.160
Why?
Cytotoxicity, Immunologic
4
2015
56
0.160
Why?
Clinical Trials as Topic
1
2022
463
0.160
Why?
Neoplasm Recurrence, Local
1
2024
630
0.160
Why?
Tumor Suppressor Proteins
2
2019
128
0.160
Why?
DNA, Single-Stranded
1
2020
88
0.150
Why?
NF-E2-Related Factor 2
1
2019
47
0.150
Why?
Oncogene Proteins
1
2019
19
0.150
Why?
Mitosis
3
2015
87
0.150
Why?
rab GTP-Binding Proteins
1
2019
23
0.150
Why?
Excitation Contraction Coupling
1
2018
3
0.150
Why?
Carcinoma, Neuroendocrine
1
2019
25
0.150
Why?
Transplantation, Heterologous
2
2017
78
0.150
Why?
Receptors, Interleukin-6
1
2018
23
0.150
Why?
Healthcare Disparities
1
2022
296
0.150
Why?
Neovascularization, Pathologic
3
2009
158
0.150
Why?
Drug Tolerance
1
2018
60
0.150
Why?
Adaptation, Physiological
2
2018
110
0.150
Why?
Pyridines
1
2019
134
0.140
Why?
Blotting, Western
3
2015
588
0.140
Why?
Myocardial Contraction
1
2018
112
0.140
Why?
Cardiomegaly
1
2018
57
0.140
Why?
Ventricular Remodeling
1
2018
65
0.140
Why?
Cell Nucleus
1
2018
188
0.140
Why?
Lung Neoplasms
1
2024
624
0.140
Why?
Glucaric Acid
1
2017
2
0.140
Why?
Drug Therapy, Combination
2
2017
399
0.140
Why?
Ferric Compounds
1
2017
16
0.140
Why?
beta Catenin
2
2015
103
0.130
Why?
Mice, Knockout
4
2023
893
0.130
Why?
Myocytes, Cardiac
1
2018
145
0.130
Why?
M Phase Cell Cycle Checkpoints
1
2017
5
0.130
Why?
Hydroxamic Acids
2
2014
38
0.130
Why?
Aerobiosis
1
2017
13
0.130
Why?
Microfilament Proteins
1
2017
44
0.130
Why?
Onium Compounds
1
2016
13
0.130
Why?
Calcium-Binding Proteins
1
2017
57
0.130
Why?
Thyroid Hormones
1
2017
22
0.130
Why?
Organophosphorus Compounds
1
2016
17
0.130
Why?
Deoxyglucose
1
2016
35
0.130
Why?
Histone Deacetylase Inhibitors
2
2014
57
0.130
Why?
Pancreatic Neoplasms
1
2019
202
0.130
Why?
Survival Analysis
6
2020
667
0.130
Why?
Inhibitor of Apoptosis Proteins
3
2015
21
0.130
Why?
Gene Deletion
2
2008
274
0.130
Why?
Syndecans
3
2006
37
0.120
Why?
RNA Interference
2
2015
185
0.120
Why?
Cell Death
1
2016
169
0.120
Why?
Ribosomal Proteins
1
2016
24
0.120
Why?
Macrophages
2
2022
360
0.120
Why?
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
2016
45
0.120
Why?
Proto-Oncogene Proteins
2
2009
149
0.120
Why?
Neoplasm Staging
4
2025
766
0.120
Why?
Proteoglycans
3
2006
86
0.120
Why?
Oncolytic Virotherapy
1
2015
21
0.120
Why?
Muscle Proteins
1
2018
348
0.120
Why?
Gene Dosage
2
2013
76
0.120
Why?
Cell Adhesion Molecules
1
2015
88
0.120
Why?
Calcium Channels
1
2015
39
0.120
Why?
Polysaccharides
1
2015
54
0.120
Why?
Receptors, Transferrin
1
2015
16
0.120
Why?
Core Binding Factor Alpha 1 Subunit
1
2015
46
0.120
Why?
Mitochondria, Heart
1
2015
40
0.120
Why?
Side-Population Cells
1
2015
3
0.110
Why?
Patient Selection
2
2023
265
0.110
Why?
Receptors, Cell Surface
1
2015
110
0.110
Why?
Serine Endopeptidases
2
2006
50
0.110
Why?
Lentivirus
1
2015
17
0.110
Why?
Retinal Dehydrogenase
1
2014
10
0.110
Why?
Transcription, Genetic
3
2018
373
0.110
Why?
Adenine
1
2015
30
0.110
Why?
Caspase 3
2
2022
91
0.110
Why?
Serum
1
2014
32
0.110
Why?
Cell Lineage
1
2014
87
0.110
Why?
Proto-Oncogene Proteins c-kit
1
2014
33
0.110
Why?
Translocation, Genetic
4
2021
265
0.110
Why?
Superoxide Dismutase
1
2014
120
0.110
Why?
Tumor Burden
3
2020
133
0.110
Why?
Piperidines
1
2015
96
0.110
Why?
Stress, Physiological
1
2015
184
0.110
Why?
Cyclins
3
2015
38
0.110
Why?
HLA Antigens
1
2014
53
0.110
Why?
Alkaline Phosphatase
2
2011
92
0.110
Why?
Glycoproteins
1
2014
122
0.110
Why?
Repressor Proteins
4
2015
150
0.110
Why?
11-beta-Hydroxysteroid Dehydrogenase Type 2
1
2013
12
0.100
Why?
Leukemia, Plasma Cell
1
2013
33
0.100
Why?
Lactate Dehydrogenases
1
2013
1
0.100
Why?
Phenotype
4
2009
794
0.100
Why?
Genome, Human
2
2021
121
0.100
Why?
Intercellular Adhesion Molecule-1
1
2013
59
0.100
Why?
Follow-Up Studies
5
2024
2282
0.100
Why?
Dose-Response Relationship, Drug
4
2020
1368
0.100
Why?
Scavenger Receptors, Class A
1
2013
39
0.100
Why?
Disease Models, Animal
4
2020
1467
0.100
Why?
Leukemia
1
2013
67
0.100
Why?
bcl-X Protein
1
2013
54
0.100
Why?
Heart
1
2015
360
0.100
Why?
Heat-Shock Proteins
1
2013
104
0.100
Why?
RNA, Small Interfering
2
2010
215
0.090
Why?
RNA, Neoplasm
3
2007
45
0.090
Why?
Forkhead Transcription Factors
2
2023
119
0.090
Why?
Clinical Trials, Phase III as Topic
2
2012
48
0.090
Why?
Drug Screening Assays, Antitumor
3
2020
136
0.090
Why?
Cysteine Proteinase Inhibitors
1
2011
21
0.090
Why?
Activated Protein C Resistance
1
2011
10
0.090
Why?
Factor V
1
2011
10
0.090
Why?
Protein Isoforms
2
2009
124
0.090
Why?
Acetylcysteine
1
2011
103
0.090
Why?
Glucocorticoids
1
2013
236
0.090
Why?
Interferon Regulatory Factor-1
1
2010
14
0.090
Why?
Cell Growth Processes
1
2010
24
0.090
Why?
HLA-A Antigens
2
2007
11
0.080
Why?
Cells, Cultured
6
2015
1568
0.080
Why?
Gene Silencing
2
2007
120
0.080
Why?
Mice, Inbred C57BL
3
2021
1872
0.080
Why?
Alleles
2
2021
277
0.080
Why?
Thrombosis
1
2012
252
0.080
Why?
Epigenesis, Genetic
2
2023
401
0.080
Why?
K562 Cells
3
2016
41
0.080
Why?
Immunophenotyping
5
2010
117
0.080
Why?
Microtubule-Associated Proteins
1
2009
61
0.080
Why?
Recombinant Proteins
1
2010
492
0.080
Why?
Bone Remodeling
1
2010
154
0.080
Why?
Chromosome Mapping
2
2006
149
0.080
Why?
HCT116 Cells
2
2020
31
0.080
Why?
Thromboembolism
1
2009
49
0.080
Why?
Mutation
3
2021
1318
0.070
Why?
Lymphocyte Subsets
1
2008
14
0.070
Why?
ras Proteins
2
2020
63
0.070
Why?
Angiogenesis Inhibitors
1
2009
184
0.070
Why?
Receptors, Immunologic
1
2008
36
0.070
Why?
Neoplasm Transplantation
2
2020
86
0.070
Why?
Breast Neoplasms
2
2007
1199
0.070
Why?
G2 Phase Cell Cycle Checkpoints
2
2020
9
0.070
Why?
Risk Assessment
3
2025
1339
0.070
Why?
Protein Tyrosine Phosphatases
1
2007
14
0.070
Why?
Adoptive Transfer
1
2007
29
0.070
Why?
Genes, abl
1
2007
2
0.070
Why?
Cross-Sectional Studies
2
2023
1665
0.070
Why?
HEK293 Cells
2
2019
231
0.070
Why?
Cancer Vaccines
1
2007
78
0.060
Why?
JNK Mitogen-Activated Protein Kinases
1
2007
72
0.060
Why?
Drug Evaluation, Preclinical
2
2021
141
0.060
Why?
Caspases
1
2007
102
0.060
Why?
Cyclin D
1
2006
18
0.060
Why?
Chromosome Banding
1
2006
24
0.060
Why?
Models, Genetic
1
2006
173
0.060
Why?
Proportional Hazards Models
2
2024
439
0.060
Why?
Palatine Tonsil
2
2003
11
0.060
Why?
DNA Damage
1
2008
306
0.060
Why?
Peptides
1
2007
234
0.060
Why?
Maf Transcription Factors, Large
1
2005
1
0.060
Why?
Gene Expression Regulation, Enzymologic
1
2007
181
0.060
Why?
Doxorubicin
2
2018
242
0.060
Why?
Data Interpretation, Statistical
1
2006
168
0.060
Why?
Protein Kinases
1
2005
72
0.060
Why?
Cyclin D1
1
2005
57
0.060
Why?
Antibody Formation
1
2005
51
0.060
Why?
Hydrogen Peroxide
2
2017
119
0.060
Why?
Protein Biosynthesis
2
2003
265
0.050
Why?
Neoplasm, Residual
1
2025
170
0.050
Why?
Base Sequence
3
2015
627
0.050
Why?
Papillomaviridae
1
2005
104
0.050
Why?
Cystadenocarcinoma, Serous
1
2004
73
0.050
Why?
Carcinoma, Papillary
1
2004
50
0.050
Why?
Transfection
2
2020
366
0.050
Why?
Mice, Inbred BALB C
2
2019
307
0.050
Why?
Consensus
1
2025
190
0.050
Why?
Drug Synergism
2
2014
148
0.050
Why?
Jurkat Cells
2
2014
28
0.050
Why?
Genetic Predisposition to Disease
1
2007
528
0.050
Why?
Extracellular Matrix Proteins
1
2004
69
0.050
Why?
Zebrafish Proteins
1
2003
24
0.050
Why?
Adipogenesis
1
2024
49
0.050
Why?
Glucose
2
2016
358
0.050
Why?
Ovariectomy
1
2024
113
0.050
Why?
Steroids
1
2024
60
0.050
Why?
PPAR gamma
1
2024
72
0.050
Why?
Sequence Analysis, RNA
1
2024
96
0.050
Why?
Integrin beta Chains
1
2023
14
0.050
Why?
Integrins
1
2023
31
0.050
Why?
Chromosomes, Human, Pair 13
1
2003
38
0.050
Why?
Oxidative Phosphorylation
1
2023
45
0.050
Why?
Receptors, Fibroblast Growth Factor
1
2002
8
0.050
Why?
Cytogenetic Analysis
1
2023
79
0.050
Why?
Chromosomes, Human, Pair 4
1
2002
30
0.050
Why?
Chromosomes, Human, Pair 14
1
2002
75
0.050
Why?
Macrophage Activation
1
2022
22
0.050
Why?
Chromosome Deletion
1
2023
139
0.050
Why?
Oncogene Proteins, Fusion
1
2002
60
0.050
Why?
Computational Biology
2
2020
209
0.050
Why?
Geography
1
2022
65
0.050
Why?
Porphyromonas gingivalis
1
2022
17
0.050
Why?
Chromatin
1
2023
141
0.050
Why?
Uterine Cervical Neoplasms
1
2005
299
0.050
Why?
Diploidy
3
2007
25
0.050
Why?
Inflammasomes
1
2022
66
0.040
Why?
DNA, Neoplasm
1
2002
146
0.040
Why?
Models, Animal
2
2015
228
0.040
Why?
Mutation Rate
1
2021
36
0.040
Why?
DNA Primers
2
2015
204
0.040
Why?
Clone Cells
1
2021
76
0.040
Why?
Proteins
1
2003
347
0.040
Why?
Proto-Oncogene Proteins p21(ras)
1
2021
68
0.040
Why?
Genes, Tumor Suppressor
1
2021
73
0.040
Why?
Ovarian Neoplasms
1
2004
458
0.040
Why?
DNA Copy Number Variations
1
2021
117
0.040
Why?
Cytokines
3
2009
621
0.040
Why?
Double-Blind Method
2
2014
718
0.040
Why?
Wnt Signaling Pathway
1
2021
95
0.040
Why?
3' Untranslated Regions
1
2020
55
0.040
Why?
Immunohistochemistry
3
2009
975
0.040
Why?
Software
1
2002
280
0.040
Why?
DNA
1
2023
543
0.040
Why?
Gene Knockout Techniques
1
2019
46
0.040
Why?
Genetic Variation
1
2020
224
0.040
Why?
Drug Discovery
1
2020
93
0.040
Why?
Crystallography, X-Ray
1
2019
156
0.040
Why?
Mice, Nude
1
2019
231
0.040
Why?
High-Throughput Nucleotide Sequencing
1
2020
174
0.040
Why?
Protein Phosphatase 2
1
2019
4
0.040
Why?
Multivariate Analysis
1
2021
600
0.040
Why?
G1 Phase
1
2019
13
0.040
Why?
Enzyme Activators
1
2019
8
0.040
Why?
Immunotherapy
1
2021
240
0.040
Why?
Protein Conformation
1
2019
177
0.040
Why?
Antibody-Dependent Cell Cytotoxicity
2
2009
12
0.040
Why?
Structure-Activity Relationship
1
2020
404
0.040
Why?
Active Transport, Cell Nucleus
1
2018
35
0.040
Why?
Wnt Proteins
2
2013
102
0.040
Why?
Calpain
1
2018
25
0.040
Why?
DNA Methylation
1
2023
583
0.040
Why?
Phosphorylation
1
2020
523
0.040
Why?
TOR Serine-Threonine Kinases
1
2019
82
0.040
Why?
Drug Resistance
1
2018
68
0.040
Why?
Autophagy
1
2020
195
0.040
Why?
Deferoxamine
1
2017
9
0.030
Why?
HT29 Cells
1
2017
14
0.030
Why?
Iron Chelating Agents
1
2017
12
0.030
Why?
Catalase
1
2017
72
0.030
Why?
Cell Cycle Checkpoints
1
2017
32
0.030
Why?
Biological Transport
1
2016
150
0.030
Why?
Chronic Disease
1
2019
585
0.030
Why?
Cell Hypoxia
1
2016
83
0.030
Why?
Endoplasmic Reticulum Stress
1
2016
49
0.030
Why?
Models, Statistical
2
2008
231
0.030
Why?
Drug Interactions
1
2016
201
0.030
Why?
Cell Line
2
2013
1018
0.030
Why?
Mice, Inbred ICR
1
2016
25
0.030
Why?
Microscopy, Electron, Transmission
1
2015
69
0.030
Why?
Transcriptional Activation
1
2016
128
0.030
Why?
Pharmacogenetics
2
2006
51
0.030
Why?
Reoviridae
1
2015
25
0.030
Why?
Vidarabine
1
2015
8
0.030
Why?
Mitoxantrone
1
2015
9
0.030
Why?
Sarcoplasmic Reticulum
1
2015
21
0.030
Why?
Genes, Dominant
1
2015
21
0.030
Why?
Myocardial Reperfusion
1
2015
13
0.030
Why?
Prostaglandin-Endoperoxide Synthases
1
2015
25
0.030
Why?
Antibodies, Monoclonal, Murine-Derived
1
2015
47
0.030
Why?
Diastole
1
2015
68
0.030
Why?
Vincristine
1
2015
88
0.030
Why?
Cytosol
1
2015
80
0.030
Why?
China
1
2015
134
0.030
Why?
Prednisone
1
2015
102
0.030
Why?
Cardiac Pacing, Artificial
1
2015
34
0.030
Why?
Ligands
1
2015
206
0.030
Why?
Microscopy, Fluorescence
1
2015
140
0.030
Why?
Vaccination
2
2007
296
0.030
Why?
Glutathione Peroxidase
1
2014
23
0.030
Why?
Cyclin B
1
2014
4
0.030
Why?
CDC2 Protein Kinase
1
2014
15
0.030
Why?
Molecular Targeted Therapy
1
2016
132
0.030
Why?
Disulfiram
1
2014
13
0.030
Why?
Portraits as Topic
1
2014
2
0.030
Why?
Cyclophosphamide
1
2015
173
0.030
Why?
Oxygen Consumption
1
2015
200
0.030
Why?
Membrane Potential, Mitochondrial
1
2014
41
0.030
Why?
Chemotherapy, Adjuvant
1
2014
121
0.030
Why?
Antigens, Differentiation, T-Lymphocyte
1
2013
8
0.030
Why?
Lectins, C-Type
1
2013
30
0.030
Why?
Veratrum Alkaloids
1
2013
5
0.030
Why?
Multidrug Resistance-Associated Proteins
1
2013
17
0.030
Why?
Calcium
1
2015
372
0.030
Why?
Isoxazoles
1
2013
15
0.030
Why?
Glutathione
1
2014
303
0.030
Why?
G1 Phase Cell Cycle Checkpoints
1
2013
17
0.030
Why?
Sulfones
1
2013
24
0.030
Why?
Electrocardiography
1
2015
279
0.030
Why?
Hedgehog Proteins
1
2013
34
0.030
Why?
Gene Expression Regulation, Leukemic
1
2013
32
0.030
Why?
Itraconazole
1
2013
38
0.030
Why?
Peptide Library
1
2013
16
0.030
Why?
Receptors, Glucocorticoid
1
2013
34
0.030
Why?
Receptors, IgG
1
2013
24
0.020
Why?
Oxidants
1
2013
51
0.020
Why?
Heart Ventricles
1
2015
264
0.020
Why?
Azacitidine
1
2013
39
0.020
Why?
ADP-ribosyl Cyclase
2
2003
4
0.020
Why?
p38 Mitogen-Activated Protein Kinases
1
2013
94
0.020
Why?
Epitopes
1
2013
62
0.020
Why?
Hydrocortisone
1
2013
113
0.020
Why?
Prospective Studies
2
2010
2424
0.020
Why?
Blood Pressure
1
2015
535
0.020
Why?
MAP Kinase Signaling System
1
2013
126
0.020
Why?
Histone Deacetylases
1
2013
51
0.020
Why?
Proto-Oncogene Proteins c-bcl-2
1
2013
128
0.020
Why?
Radiation, Ionizing
1
2013
101
0.020
Why?
Myocardium
1
2015
477
0.020
Why?
Osteoblasts
2
2006
473
0.020
Why?
Clinical Trials, Phase II as Topic
1
2012
47
0.020
Why?
Viper Venoms
1
2011
6
0.020
Why?
Protein C
1
2011
20
0.020
Why?
Risk
1
2011
312
0.020
Why?
Bone Density Conservation Agents
1
2010
75
0.020
Why?
Diphosphonates
1
2010
92
0.020
Why?
Databases as Topic
1
2009
38
0.020
Why?
Parathyroid Hormone
1
2010
149
0.020
Why?
Lymphocytes
1
2010
146
0.020
Why?
Cytoskeleton
1
2008
39
0.020
Why?
Genotype
1
2009
563
0.020
Why?
Twins
1
2007
33
0.020
Why?
STAT Transcription Factors
1
2007
8
0.020
Why?
Cytological Techniques
1
2007
13
0.020
Why?
NF-kappa B p52 Subunit
1
2007
6
0.020
Why?
NF-kappa B p50 Subunit
1
2007
17
0.020
Why?
Antibodies, Monoclonal, Humanized
1
2009
232
0.020
Why?
I-kappa B Kinase
1
2007
20
0.020
Why?
Karyotyping
1
2007
78
0.020
Why?
T-Lymphocytes, Cytotoxic
1
2007
65
0.020
Why?
HLA-A2 Antigen
1
2007
11
0.020
Why?
Benzamides
1
2007
50
0.020
Why?
Antigen Presentation
1
2007
26
0.020
Why?
Remission Induction
1
2007
218
0.020
Why?
Polysaccharide-Lyases
1
2007
7
0.020
Why?
Leukocytes, Mononuclear
1
2007
122
0.020
Why?
Plasmids
1
2007
164
0.020
Why?
Enzyme-Linked Immunosorbent Assay
1
2007
234
0.020
Why?
Interferon-gamma
1
2007
172
0.020
Why?
Tissue Culture Techniques
1
2007
42
0.020
Why?
Enzyme Activation
1
2007
269
0.020
Why?
Multigene Family
1
2006
49
0.020
Why?
Piperazines
1
2007
125
0.020
Why?
Anticoagulants
1
2009
276
0.020
Why?
Neoplasms, Experimental
1
2007
112
0.020
Why?
Diagnosis, Differential
1
2010
1031
0.020
Why?
Antineoplastic Agents, Hormonal
1
2006
53
0.020
Why?
Dendritic Cells
1
2007
133
0.020
Why?
Polymerase Chain Reaction
1
2007
460
0.020
Why?
Incidence
1
2009
1070
0.020
Why?
Receptors, Estrogen
1
2007
131
0.020
Why?
Gelatinases
1
2006
32
0.020
Why?
Chromosomes, Human
1
2006
41
0.020
Why?
Endopeptidases
1
2006
63
0.020
Why?
Rabbits
1
2006
371
0.020
Why?
Coculture Techniques
1
2006
142
0.020
Why?
Combined Modality Therapy
1
2007
634
0.010
Why?
Cyclin D3
1
2005
5
0.010
Why?
Cyclin D2
1
2005
21
0.010
Why?
Adipocytes
1
2006
130
0.010
Why?
Trisomy
1
2005
35
0.010
Why?
Oligonucleotide Probes
1
2004
19
0.010
Why?
Stem Cells
1
2006
182
0.010
Why?
Molecular Sequence Data
1
2006
766
0.010
Why?
Epithelium
1
2004
64
0.010
Why?
Endothelium, Vascular
1
2006
257
0.010
Why?
Ovary
1
2004
103
0.010
Why?
Endothelial Cells
1
2006
281
0.010
Why?
Bacterial Proteins
1
2007
337
0.010
Why?
Databases, Factual
1
2007
714
0.010
Why?
RNA, Complementary
1
2003
2
0.010
Why?
Autocrine Communication
1
2003
7
0.010
Why?
Paracrine Communication
1
2003
13
0.010
Why?
Cell Separation
1
2003
73
0.010
Why?
Metaphase
1
2003
46
0.010
Why?
Receptor, Fibroblast Growth Factor, Type 3
1
2002
18
0.010
Why?
Biopsy
1
2005
599
0.010
Why?
NAD+ Nucleosidase
1
2002
2
0.010
Why?
Melanoma-Specific Antigens
1
2002
3
0.010
Why?
Cell Communication
1
2003
72
0.010
Why?
Antigens, Differentiation
1
2002
16
0.010
Why?
Gene Expression Regulation, Developmental
1
2003
147
0.010
Why?
Cohort Studies
1
2006
1541
0.010
Why?
Immunoglobulins
1
2002
76
0.010
Why?
Database Management Systems
1
2002
27
0.010
Why?
Reproducibility of Results
1
2005
1214
0.010
Why?
Logistic Models
1
2003
925
0.010
Why?
Magnetic Resonance Imaging
1
2003
1518
0.010
Why?
Zhan's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description